Patients with end stage renal disease (GFR <15mL/min/1.73m 2): maximum daily dose is 30 mg. Administration of 60 mg Vyvanse chewable tablet with food (a high-fat meal) decreases the exposure (C ...
30 mg, 40 mg, 50 mg, and 60 mg. The approved ANDA has been deemed bioequivalent, or therapeutically equivalent (AB Rating), to the reference listed drug (RLD), Vyvanse chewable tablets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback